Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are detected and treated, offering a more precise and potentially less harmful alternative to chemotherapy, radiation, and surgery.

Published in Cell Reports.

The study advances photothermal therapy, a treatment approach that uses light to generate heat inside tumours and destroy cancer cells.

The NYU Abu Dhabi team designed tiny, biocompatible and biodegradable nanoparticles that carry a dye activated by near-infrared light.

When exposed to this light, the particles heat up damaging tumour tissue while minimising harm to healthy cells.

Near-infrared light was chosen specifically as it penetrates the body to greater depth than visible light, thereby enabling treatment of tumours that are not close to the surface.

A key challenge in photothermal therapy is keeping the light-responsive material stable in the body and efficiently delivering it to tumours.

Many existing photothermal agents degrade quickly, clear from the bloodstream, or fail to enter cancer cells efficiently.

To address this, the researchers developed nanoparticles made from hydroxyapatite, a mineral found in bones and teeth.

The particles are coated with lipids and polymers, which help them circulate longer in the bloodstream and avoid immune detection, allowing more of the therapeutic material to reach the tumours.

The particles also take advantage of the mildly acidic environment found in tumours.

A peptide (a small protein) on their surface becomes active under these conditions, helping the nanoparticles efficiently enter cancer cells while largely avoiding healthy tissue.

The researchers found that the nanoparticles are highly stable, effectively protect the dye cargo from degradation and accumulate efficiently in tumours.

Upon activation by near-infrared light, generate localised heat that destroys tumour tissue and produce fluorescent and thermal signals that allow tumours to be visualised and treatment effects to be monitored in real time.

“This work brings together targeted treatment and imaging in a single, biocompatible and biodegradable system,” said Mazin Magzoub, senior author of the study and associate professor of biology at NYU Abu Dhabi.

“By addressing key challenges in delivering therapeutic agents to tumours, our approach has the potential to improve cancer treatment precision. 

The findings highlight the promise of this nanoparticle as an integrated system for cancer diagnosis and therapy, and an important step toward safer, more effective light-based cancer treatments.

Times Higher Education ranks NYU among the world’s top 31 universities, making NYU Abu Dhabi the highest globally ranked university in the UAE.

Alumni achievements include 24 Rhodes Scholars, underscoring the calibre of talent nurtured at the University.

On the faculty and research front, NYUAD now has four Nobel Laureates and established more than 90 faculty labs and projects, producing over 9,500 internationally recognised publications.

According to the Nature Index, NYUAD ranks number one in the UAE for publications in the world’s top science journals.

Source: New York University